
No. of Pages: 113 | Report Code: TIPRE00022126 | Category: Life Sciences
No. of Pages: 113 | Report Code: TIPRE00022126 | Category: Life Sciences
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Key Market Drivers
4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
4.2 Market Restraint
4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
4.4.1 Increasing Demand for Personalized Medicine and Genomics
5.1 South & Central America In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6.1 Overview
6.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
6.3.1 Overview
6.3.2 Reagents and Kits: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
6.4.1 Overview
6.4.2 Software and Services: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
6.5.1 Overview
6.5.2 Instruments: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.1 Overview
7.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
7.3.1 Overview
7.3.2 Immunoassay/ Immunochemistry: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
7.4.1 Overview
7.4.2 Clinical Chemistry: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
7.6.1 Overview
7.6.2 Microbiology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
7.7.1 Overview
7.7.2 Blood Glucose Self-Monitoring: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
7.8.1 Overview
7.8.2 Coagulation and Hemostasis: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
7.9.1 Overview
7.9.2 Hematology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
7.10.1 Overview
7.10.2 Urinalysis: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.1 Overview
8.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
8.3.1 Overview
8.3.2 Infectious Diseases: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
8.4.1 Overview
8.4.2 Diabetes: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
8.7.1 Overview
8.7.2 Autoimmune Diseases: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
8.8.1 Overview
8.8.2 Nephrology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.1 Overview
9.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
9.4.1 Overview
9.4.2 Laboratories: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1 South & Central America In-Vitro Diagnostics Market
10.1.1 Overview
10.1.2 South & Central America In-Vitro Diagnostics Market, by Country
10.1.2.1 Brazil: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 Brazil: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.1.4 Brazil: South & Central America In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.1.5 Brazil: South & Central America In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.6 Brazil: South & Central America In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 Argentina: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Argentina: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.2.4 Argentina: South & Central America In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.2.5 Argentina: South & Central America In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.6 Argentina: South & Central America In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.3.4 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3.5 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.6 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1 Organic Developments
11.1.1 Overview
11.2 Inorganic Developments
11.2.1 Overview
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Siemens AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sysmex Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Qiagen NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13.1 About Us
13.2 Glossary of Terms
Table 1. South & Central America In-Vitro Diagnostics Market Segmentation
Table 2. Brazil South & Central America In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil South & Central America In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil South & Central America In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil South & Central America In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Argentina South & Central America In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina South & Central America In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina South & Central America In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina South & Central America In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 12. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms, South & Central America In-Vitro Diagnostics Market
Figure 1. South & Central America In-Vitro Diagnostics Market Segmentation, By Country
Figure 2. South & Central America In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 3. South & Central America In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030
Figure 5. South & Central America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 6. Reagents and Kits: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Software and Services: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Instruments: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 10. Immunoassay/ Immunochemistry: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Clinical Chemistry: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Diagnostics: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microbiology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Blood Glucose Self-Monitoring: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation and Hemostasis: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hematology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Urinalysis: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 20. Infectious Diseases: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diabetes: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Oncology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Cardiology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Autoimmune Diseases: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Nephrology: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Laboratories: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Homecare: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. South & Central America: South & Central America In-Vitro Diagnostics Market, By Key Country – Revenue (2022) (US$ Million)
Figure 33. South & Central America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 34. Brazil: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Argentina: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Rest of South & Central America: South & Central America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)